MD LIO

Dosage

Children: Refer to specific medications used to treat the particular disease for dosing information.

Adults: Refer to specific medications used to treat the particular disease for dosing information.

Mechanism of action

The mechanism of action varies significantly depending on the specific disease in question. For infectious diseases, pathogens may interact with host cells, leading to inflammation, immune response activation, or tissue damage. Chronic diseases often involve complex interactions between genetic factors, lifestyle choices, and environmental influences. For example, in autoimmune diseases, the immune system mistakenly targets healthy cells, leading to inflammation and tissue destruction.

Pharmacodynamics

Pharmacodynamics of disease involves understanding how the disease state affects physiological functions and the body's response to treatment. In infectious diseases, the presence of pathogens can lead to altered immune responses, while chronic diseases may involve changes in metabolic pathways, hormonal balances, or cellular functions. Medications targeting disease processes aim to restore normal function, alleviate symptoms, or eradicate pathogens.

Pharmacokinetics

Pharmacokinetics is not applicable to the term 'disease' as it refers to the movement of drugs within the body, including absorption, distribution, metabolism, and excretion of specific medications used to treat diseases. Each medication will have its own pharmacokinetic profile depending on its chemical properties and the disease being treated.

Indications

• Prevention of Marek's disease in poultry
• Vaccination in young chickens to protect against MDV

Dosage

Children: Refer to the specific manufacturer's guidelines for vaccination protocols in young poultry. Doses may vary based on the vaccine type used.

Adults: Refer to the specific manufacturer's guidelines for vaccination protocols in adult poultry. Doses may vary based on the vaccine type used.

Mechanism of action

Marek's disease virus primarily functions by integrating its DNA into the host cell's genome, leading to transformation of the infected cells. This results in the proliferation of T-cells and the formation of lymphomas, causing clinical disease. The vaccines work by providing an immune response that prevents the virus from establishing infection.

Pharmacodynamics

The pharmacodynamics of Marek's disease vaccines involve the stimulation of the immune system to recognize and combat the Marek's disease virus. The immune response generated includes both humoral and cellular immunity, which helps prevent the disease's onset and reduces the severity of clinical signs in vaccinated birds.

Pharmacokinetics

The pharmacokinetics of Marek's disease vaccines are not directly applicable as they are biological products rather than conventional drugs. However, once administered, the vaccine components are taken up by the immune system, leading to the development of immunity over a period of time. The onset of immunity typically occurs within a few weeks after vaccination.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Skin rash
• Allergic reactions

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of hypersensitivity
• Consider potential interactions with other medications

Pregnancy

The safety of Marek's vaccine in pregnant women has not been established. Caution is advised.

Breast-feeding

It is unknown if Marek's vaccine is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at 2 to 8 degrees Celsius. Protect from light and do not freeze.

Formulations

• Live attenuated vaccine